Showing results (201-210 of 255) with videos related to
Sort By:
Pageof 26
RSC Chemical Biology|June 29, 2026
Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metaboliteBanhi Biswas, Junlin Zhuo, Jürgen Bosch, et al.Neuropharmacology|December 9, 2017
Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in ratsBrendan J Tunstall, Chelsea P Ho, Jianjing Cao, et al.Nanotheranostics|January 3, 2022
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosisKristen R Hollinger, Anjali Sharma, Carolyn Tallon, et al.JCI Insight|June 8, 2018
NaV1.1 inhibition can reduce visceral hypersensitivityJuan Salvatierra, Joel Castro, Andelain Erickson, et al.Journal of Medicinal Chemistry|August 1, 2017
Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic PainRana Rais, Jan Vávra, Tomáš Tichý, et al.Angiogenesis|July 9, 2016
Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptideRebecca E Conway, Camilo Rojas, Jesse Alt, et al.Brain, Behavior, and Immunity|March 13, 2026
Sex-specific gut mycobiome dysbiosis activates macrophage dectin-1 signaling to drive neurobehavioral deficits in EcoHIV-infected miceYannan Li, Shinji Sakamoto, Matthew D Smith, et al.Journal of Medicinal Chemistry|April 17, 2020
Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's DiseaseMichal Šála, Kristen R Hollinger, Ajit G Thomas, et al.Journal of Medicinal Chemistry|December 10, 2016
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter InhibitorsJianjing Cao, Rachel D Slack, Oluyomi M Bakare, et al.Journal of Medicinal Chemistry|May 31, 2012
Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffoldsDoris Stoermer, Dilrukshi Vitharana, Niyada Hin, et al.Pageof 26